Feasibility Study of Intraperitoneal Docetaxel Combined With Intravenous Cisplatin and Oral TS-ONE for Gastric Cancer Patients With Peritoneal Carcinomatosis
Phase of Trial: Phase I
Latest Information Update: 10 May 2018
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
- Indications Carcinoma; Gastric cancer
- Focus Adverse reactions
- 01 May 2018 Status changed from recruiting to completed.
- 02 Nov 2016 Planned End Date changed from 1 May 2017 to 1 Sep 2018.
- 02 Nov 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Dec 2017.